Geriatrics and Medication Review
Frailty, falls and deprescribing
Aimed at function and the patient's own goals as much as at any diagnosis. The engine grades frailty with the Clinical Frailty Scale, works through falls, delirium, cognition, continence, nutrition and function, and reviews every medicine for its indication, benefit, harm and time to benefit. Recommendations to stop or reduce a drug come with a tapering plan and what to watch for, set against what the patient wants from treatment.
Who it is for
- Geriatricians, orthogeriatricians and general physicians on acute and rehabilitation wards
- Residents and registrars admitting older patients after a fall, with delirium or with an unexplained decline
- Clinical pharmacists and doctors carrying out structured medication reviews at admission or discharge
What it does
Grades frailty and lets it shape the plan
Scores the Clinical Frailty Scale from the account of the patient's usual function, and lets that score and the patient's own priorities set the intensity of tests and treatment.
Reviews each medicine against named criteria
Tests each medicine against STOPP/START or the Beers criteria by name and against the patient: why it was started, whether it still helps, what harm it may cause, whether its benefit will arrive in time to matter, and whether the dose suits kidney function.
Adds up hidden burdens
Totals the anticholinergic burden across the list, looks for prescribing cascades in which one drug treats another's side effect, and flags duplications and combinations of sedatives.
Works up falls as a multifactorial problem
Assesses falls from every angle: postural blood pressure, the drugs most likely to blame, gait, balance, eyesight, cognition, shoes and the home, and bone health with a FRAX fracture-risk estimate.
Screens for and manages delirium
Screens with the 4AT or the Confusion Assessment Method, then hunts for precipitants such as sepsis, pain, constipation, a full bladder, dehydration, hypoxia, new drugs or withdrawal, and puts non-drug measures before any sedative.
Plans deprescribing safely
Pairs every recommendation to stop or reduce with a taper and the withdrawal or rebound effects to watch for, which matters most for benzodiazepines, antipsychotics, opioids, proton pump inhibitors and blood pressure drugs.
How it works
- The clinician gives age, living situation, baseline mobility and cognition, the medication list with indications, falls history, lying and standing blood pressure, weight, continence and the patient's priorities if known.
- The engine assesses the domains of comprehensive geriatric assessment and grades frailty.
- It looks for atypical presentations of acute illness and works up falls, delirium or cognitive change.
- It reviews every medicine in a table giving the indication, the concern, the recommendation and how to taper and monitor.
- The plan covers nutrition, continence, carers, safeguarding and advance care planning, and the report ends with numbered references and US product labels for named medicines.
What to include
- Age, living situation, mobility and cognition at baseline
- The full medication list with indications where known
- Falls, blood pressure lying and standing, weight and continence
- The patient's own priorities, if known
Example cases
- 86F, 3 falls in 2 months, on amlodipine, bendroflumethiazide, amitriptyline, zopiclone, oxybutynin and tramadol. What should stop or change?
- 89M with advanced dementia in a care home on atorvastatin, alendronate, donepezil and aspirin. Deprescribing plan?
- Frail 84-year-old with postural drop of 34 mmHg, on 3 antihypertensives and tamsulosin. Approach?
What the report contains
- Conclusion and Recommendation
- Differential Diagnosis
- Management Plan
- Medication Review
- Information Needed
- Key Evidence & References
Limits
- It cannot watch the patient walk, measure a postural blood pressure or see the home, and its frailty grade depends on the description of baseline function it is given.
- Deprescribing decisions belong to the patient, family and treating team. The engine sets out options and trade-offs but cannot know every reason a medicine was started.
- STOPP/START and Beers are explicit tools, not substitutes for judgement; licensed doses differ between countries, and local falls and delirium pathways take precedence.
Frequently asked questions
What is the difference between STOPP/START and the Beers criteria?
Both are explicit lists for reviewing prescribing in older adults. The Beers criteria, from the American Geriatrics Society, list potentially inappropriate medicines to avoid or use with caution. STOPP/START, developed in Europe, pairs criteria for potentially inappropriate prescribing with criteria for beneficial medicines that are often omitted. The engine names the set it applies.
Which medicines most often contribute to falls?
Sedatives and hypnotics, antidepressants, antipsychotics, opioids, anticonvulsants, antihypertensives and diuretics, glucose-lowering drugs and medicines with anticholinergic effects are the usual fall-risk-increasing drugs, and risk rises with the number taken. The engine identifies them in the list and suggests what to reduce or stop first.
How should a benzodiazepine be withdrawn in an older patient?
Gradually, by reducing the dose in small steps over weeks to months, more slowly towards the end and with the patient's agreement, while watching for withdrawal symptoms, rebound insomnia and anxiety. Abrupt cessation after long-term use risks withdrawal seizures and delirium. The engine gives a tapering schedule and a follow-up plan.
What is the Clinical Frailty Scale?
A nine-point scale, from very fit to terminally ill, based on clinical judgement of a person's function and dependence before the current illness. It helps frame decisions about investigation, treatment intensity and escalation, but it is not a decision tool on its own. The engine grades it from the description given.
Related articles
Clinical article
Falls and polypharmacy: a structured medication review for the older patient who falls
A structured medication review for older people who fall: fall-risk-increasing drugs, orthostatic hypotension, anticholinergic burden and safe deprescribing.
7 min read
Clinical article
CYP3A4 interactions that harm patients: statins, macrolides and anticoagulants
The CYP3A4 interactions most likely to harm patients: clarithromycin with statins, calcium channel blockers, colchicine and DOACs, and how to manage each.
7 min read
Guide
From patient intake form to consultation: starting with the history already taken
How Sana Health intake forms work, from a shared link to a consultation in any engine, and how to use a patient-completed history well and safely.
5 min read
Clinical article
Opioid conversion and anticipatory prescribing in the last days of life
For hospital doctors: converting opioids between drugs and routes, renal impairment, subcutaneous infusions and anticipatory prescribing at end of life.
7 min read
Related engines
Interactions, dose adjustment and monitoring
Structured assessment and safe prescribing
Fractures, trauma surveys and limb emergencies